1. 1555O_PRMagnitude of clinical benefit of cancer drugs and time to health technology assessment (HTA) decisions in Europe. (23rd October 2018) Authors: Hwang, T; Vokinger, K; Tibau, A; Gyawali, B; Naci, H; Franklin, J M; Beall, R; Kesselheim, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1564PDMagnitude of clinical benefit of trials supporting US Food and Drug Administration (FDA) approval of breakthrough and non-breakthrough drugs. (23rd October 2018) Authors: Molto Valiente, C; Borrell, M; Hwang, T; Gich Saladich, I; Barnadas, A; Amir, E; Kesselheim, A; Tibau, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Role of Niacin in Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis. (13th November 2019) Authors: D'Andrea, E; Hey, S; Ramirez, C L; Kesselheim, A Journal: European journal of public health Issue: Volume 29(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗